Skip to content

CHIESI

Active
Public limited companyfounded 201016 yrs activeLuchthaven Brussel Nationaal 1 K, 1930 Zaventem, BelgiumKBO/BCE: BE 0826.654.883
Summary

CHIESI has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.1m and a net result of €2.9m. Equity is growing by ~9.1% per year across the filed fiscal years. Its solvency ranks better than 10% of 5071 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability67▼-2
Solvency31▼-6
Growth78▲+2
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100,000 at 30 days acceptable
Liquidity tight (current ratio 1.04 against 1.12 in 2024; short-term debt: 93.3% and cash: 0% of total assets), and 93.6% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
6.4%
Return on assets
8.9%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 16 years 0 20 y
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 5071 sector peers (2025).
NBB · sector comparison
Position among 5071 sector peers
Solvency
better than 10%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-04-2026, 94 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
94 d early
2024
59 d early
2023
47 d early
2022
32 d early
2021
72 d early
2020
66 d early
2019
18 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 55 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 2 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 15 June 2010, CHIESI was incorporated by Chiesi Farmaceutici S.p.A. and Chiesi GmbH, with a starting capital of EUR 1.5 million.12 The registered office moved to Diegem in 2016 and to Zaventem in 2025.34 Of the 5 current board members, Stephane Piret has served longest, since 2015.5 Revenue went from EUR 33 million in 2018 to EUR 81 million in 2025 and headcount from 49.2 to 47.1 full-time equivalents.6

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 24-06-2010
  3. 3Belgian State Gazette, 10-05-2016
  4. 4Belgian State Gazette, 13-05-2025
  5. 5Belgian State Gazette, 12-05-2026
  6. 6National Bank, annual accounts 2018 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€80.6m▲ 22.2%
2024 · €66.0m
EBIT margin
4.9%▲ 0.5pp
2024 · 4.4%
Net result
€2.9m▲ 36.5%
2024 · €2.1m
Working capital
€1.1m▼ 40.3%
2024 · €1.9m
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€53.4m▲ 19.1%€55.2m▲ 3.3%€56.9m▲ 3.1%€66.0m▲ 15.9%€80.6m▲ 22.2%
Operating result€2.0m€2.3m▲ 11.4%€2.7m▲ 20.7%€2.9m▲ 5.5%€3.9m▲ 36.3%
Net result€1.6mabove the sector's middle half€1.7mabove the sector's middle half▲ 11.3%€2.1mabove the sector's middle half▲ 20.5%€2.1mabove the sector's middle half▲ 0.6%€2.9mabove the sector's middle half▲ 36.5%
EBIT margin3.8%▲ 7.0pp4.1%▲ 0.3pp4.8%▲ 0.7pp4.4%▼ 0.4pp4.9%▲ 0.5pp
Equity€90,332below the sector's middle half€1.8mwithin the sector's middle half▲ 1,929%€2.0mwithin the sector's middle half▲ 8.2%€2.1mwithin the sector's middle half▲ 7.8%€2.1mwithin the sector's middle half▼ 2.8%
Total assets€17.8mabove the sector's middle half▼ 0.7%€15.2mabove the sector's middle half▼ 14.8%€18.6mabove the sector's middle half▲ 22.6%€18.0mabove the sector's middle half▼ 2.9%€32.4mabove the sector's middle half▲ 79.7%
Debt€17.7m▲ 10.0%€13.3m▼ 24.7%€16.6m▲ 24.8%€15.9m▼ 4.2%€30.4m▲ 90.8%
Working capital-€821,159below the sector's middle half€1.2mwithin the sector's middle half€1.6mwithin the sector's middle half▲ 29.4%€1.9mwithin the sector's middle half▲ 17.1%€1.1mwithin the sector's middle half▼ 40.3%
Solvency0.5%below the sector's middle half▲ 8.7pp12.1%below the sector's middle half▲ 11.6pp10.7%below the sector's middle half▼ 1.4pp11.8%below the sector's middle half▲ 1.2pp6.4%below the sector's middle half▼ 5.4pp
Current ratio0.95below the sector's middle half▼ 0.101.09below the sector's middle half▲ 0.141.10below the sector's middle half=1.12below the sector's middle half▲ 0.021.04below the sector's middle half▼ 0.08
Return on assets (ROA)8.8%within the sector's middle half▲ 19.0pp11.5%above the sector's middle half▲ 2.7pp11.3%above the sector's middle half▼ 0.2pp11.7%above the sector's middle half▲ 0.4pp8.9%above the sector's middle half▼ 2.8pp
Staff (FTE)46.6above the sector's middle half▼ 13.5%36.5above the sector's middle half▼ 21.7%34.2above the sector's middle half▼ 6.3%38.4above the sector's middle half▲ 12.3%47.1above the sector's middle half▲ 22.7%
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
€0€1.0m€2.0m€3.0m€4.0mOperating result 2021: €2.0m€2.0mNet result 2021: €1.6m€1.6mOperating result 2022: €2.3m€2.3mNet result 2022: €1.7m€1.7mOperating result 2023: €2.7m€2.7mNet result 2023: €2.1m€2.1mOperating result 2024: €2.9m€2.9mNet result 2024: €2.1m€2.1mOperating result 2025: €3.9m€3.9mNet result 2025: €2.9m€2.9m20212022202320242025€0€1m€2m€3m€4mOperating result 2023: €2.7m€2.7mNet result 2023: €2.1m€2.1mOperating result 2024: €2.9m€2.9mNet result 2024: €2.1m€2.1mOperating result 2025: €3.9m€3.9mNet result 2025: €2.9m€2.9m202320242025
The operating result has risen four years in a row; 2025 is 36% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €32.4m
Fixed assets €1.1m ▲ 292%
Current assets €31.4m ▲ 76.5%
Equity and liabilities €32.4m
Equity €2.1m ▼ 2.8%
Debt €30.4m ▲ 90.8%
Debt's share of the balance-sheet total rises from 88.2% to 93.6%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€4.2m▲
2024 · €3.2m
Cash flow
€3.1m▲
2024 · €2.4m
Quick ratio
0.80▲
2024 · 0.68
Debt to equity
14.62▲
2024 · 7.44
ROE
138.8%▲
2024 · 98.8%
Interest coverage
159.27▲
2024 · 73.37
Debt ≤ 1 year
€30.3m▲
2024 · €15.9m
Income taxes
€1.1m▲
2024 · €819,672
Staff costs
€7.9m▲
2024 · €6.8m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 536 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 96% are still going.

  • Small
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
3.4% stopped otherwise
96% still going

For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 536 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 69 lines
Balance sheet Code20242025
Assets
Total assets20/58€18.0m€32.4m▲
Fixed assets21/28€273,568€1.1m▲
Intangible fixed assets21€18,821€4,854▼
Tangible fixed assets22/27€254,748€1.1m▲
Furniture and vehicles24€185,638€471,545▲
Other tangible fixed assets26€69,109€461,477▲
Assets under construction and advance payments27-€134,330
Current assets29/58€17.8m€31.4m▲
Stocks and contracts in progress3€6.9m€7.1m▲
Stocks30/36€6.9m€7.1m▲
Goods purchased for resale34€6.9m€7.1m▲
Amounts receivable within one year40/41€10.2m€24.1m▲
Trade receivables40€9.2m€14.7m▲
Other amounts receivable41€1.0m€9.5m▲
Cash at bank and in hand54/58€479,864€2,870▼
Deferred charges and accrued income490/1€139,541€123,853▼
Equity and liabilities
Total equity and liabilities10/49€18.0m€32.4m▲
Equity10/15€2.1m€2.1m▼
Contributions10/11€1.5m€1.5m=
Capital10€1.5m€1.5m=
Issued capital100€1.5m€1.5m=
Reserves13€150,000€150,000=
Non-distributable reserves130/1€150,000€150,000=
Legal reserve130€150,000€150,000=
Profit (loss) carried forward14€488,159€427,522▼
Amounts payable17/49€15.9m€30.4m▲
Amounts payable within one year42/48€15.9m€30.3m▲
Trade debts44€11.1m€22.7m▲
Suppliers440/4€11.1m€22.7m▲
Taxes, remuneration and social security45€2.8m€4.6m▲
Taxes450/3€1.0m€2.5m▲
Remuneration and social security454/9€1.8m€2.1m▲
Other amounts payable47/48€2.0m€2.9m▲
Accrued charges and deferred income492/3-€107,340
Income statement Code20242025
Operating income70/76A€68.5m€84.0m▲
Turnover70€66.0m€80.6m▲
Other operating income74€2.5m€3.4m▲
Operating charges60/66A€65.6m€80.0m▲
Goods for resale, raw materials and consumables60€43.0m€54.5m▲
Purchases600/8€45.2m€54.6m▲
Change in stocks: decrease (increase)609-€2.2m-€172,275▲
Services and other goods61€8.0m€8.5m▲
Remuneration, social security and pensions62€6.8m€7.9m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€269,405€220,060▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€18,789€3,905▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€0-
Other operating charges640/8€7.5m€8.9m▲
Operating profit (loss)9901€2.9m€3.9m▲
Financial income75/76B€90,780€62,650▼
Recurring financial income75€90,780€62,650▼
Income from current assets751€89,987€62,003▼
Other financial income752/9€793€647▼
Financial charges65/66B€57,096€56,875▼
Recurring financial charges65€57,096€56,875▼
Debt charges650€43,173€26,175▼
Other financial charges652/9€13,923€30,700▲
Profit (loss) for the period before taxes9903€2.9m€4.0m▲
Income taxes67/77€819,672€1.1m▲
Taxes670/3€819,672€1.1m▲
Tax adjustments and reversals of tax provisions77€0-
Profit (loss) for the period9904€2.1m€2.9m▲
Profit (loss) for the period to be appropriated9905€2.1m€2.9m▲
Appropriation of the result
Profit (loss) to be appropriated9906€2.4m€3.4m▲
Profit (loss) brought forward from the previous period14P€332,585€488,159▲
Transfer to equity691/2€0-
To the legal reserve6920€0-
Profit to be distributed694/7€2.0m€2.9m▲
Return on contributions (dividend)694€2.0m€2.9m▲
Social balance
Average headcount (FTE)908738.447.1▲

The notes to these accounts (46 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A€54.0m€55.5m€58.3m€68.5m€84.0m▲ 22.7%
Turnover70€53.4m€55.2m€56.9m€66.0m€80.6m▲ 22.2%
Other operating income74€187,405€237,555€1.4m€2.5m€3.4m▲ 34.3%
Non-recurring operating income76A€394,890€10,000€0---
Operating charges60/66A€52.0m€53.2m€55.5m€65.6m€80.0m▲ 22.1%
Goods for resale, raw materials and consumables60€32.3m€34.9m€37.0m€43.0m€54.5m▲ 26.6%
Purchases600/8€30.3m€35.9m€36.9m€45.2m€54.6m▲ 21.0%
Change in stocks: decrease (increase)609€2.0m-€1.0m€107,568-€2.2m-€172,275▲ 92.0%
Services and other goods61€6.2m€7.9m€7.4m€8.0m€8.5m▲ 7.2%
Remuneration, social security and pensions62€10.1m€5.3m€5.0m€6.8m€7.9m▲ 15.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€351,345€421,622€343,150€269,405€220,060▼ 18.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€130,384€9,228-€9,228€18,789€3,905▼ 79.2%
Provisions for liabilities and charges: additions (uses and reversals)635/8€0--€21,955€0--
Other operating charges640/8€6.0m€4.7m€5.8m€7.5m€8.9m▲ 19.7%
Non-recurring operating charges66A-€2.9m€0----
Operating profit (loss)9901€2.0m€2.3m€2.7m€2.9m€3.9m▲ 36.3%
Financial income75/76B€0€69€58,669€90,780€62,650▼ 31.0%
Recurring financial income75€0€69€58,669€90,780€62,650▼ 31.0%
Income from financial fixed assets750-€69€0---
Income from current assets751--€57,442€89,987€62,003▼ 31.1%
Other financial income752/9€0-€1,227€793€647▼ 18.5%
Financial charges65/66B€14,981€58,916€54,755€57,096€56,875▼ 0.4%
Recurring financial charges65€14,981€58,916€54,755€57,096€56,875▼ 0.4%
Debt charges650€8,571€55,325€46,386€43,173€26,175▼ 39.4%
Other financial charges652/9€6,411€3,591€8,369€13,923€30,700▲ 121%
Profit (loss) for the period before taxes9903€2.0m€2.2m€2.8m€2.9m€4.0m▲ 34.9%
Income taxes67/77€462,499€474,496€650,765€819,672€1.1m▲ 30.6%
Taxes670/3€462,499€474,576€741,484€819,672€1.1m▲ 30.6%
Tax adjustments and reversals of tax provisions77-€79€90,719€0--
Profit (loss) for the period9904€1.6m€1.7m€2.1m€2.1m€2.9m▲ 36.5%
Profit (loss) for the period to be appropriated9905€1.6m€1.7m€2.1m€2.1m€2.9m▲ 36.5%
Line20212022202320242025Change
Assets
Total assets20/58€17.8m€15.2m€18.6m€18.0m€32.4m▲ 79.7%
Fixed assets21/28€943,446€624,794€390,947€273,568€1.1m▲ 292%
Intangible fixed assets21€351,362€186,833€104,911€18,821€4,854▼ 74.2%
Tangible fixed assets22/27€592,084€437,961€286,036€254,748€1.1m▲ 319%
Furniture and vehicles24€326,057€225,897€162,964€185,638€471,545▲ 154%
Other tangible fixed assets26€230,997€177,034€123,072€69,109€461,477▲ 568%
Assets under construction and advance payments27€35,030€35,030€0-€134,330-
Current assets29/58€16.9m€14.5m€18.2m€17.8m€31.4m▲ 76.5%
Stocks and contracts in progress3€3.9m€4.9m€4.8m€6.9m€7.1m▲ 2.4%
Stocks30/36€3.9m€4.9m€4.8m€6.9m€7.1m▲ 2.4%
Goods purchased for resale34€3.9m€4.9m€4.8m€6.9m€7.1m▲ 2.4%
Amounts receivable within one year40/41€12.2m€9.6m€13.3m€10.2m€24.1m▲ 136%
Trade receivables40€11.8m€8.0m€12.2m€9.2m€14.7m▲ 59.8%
Other amounts receivable41€381,136€1.6m€1.1m€1.0m€9.5m▲ 811%
Cash at bank and in hand54/58€701,353€10,434€10,506€479,864€2,870▼ 99.4%
Deferred charges and accrued income490/1€96,607€45,029€117,536€139,541€123,853▼ 11.2%
Equity and liabilities
Total equity and liabilities10/49€17.8m€15.2m€18.6m€18.0m€32.4m▲ 79.7%
Equity10/15€90,332€1.8m€2.0m€2.1m€2.1m▼ 2.8%
Contributions10/11€1.5m€1.5m€1.5m€1.5m€1.5m=
Capital10€1.5m€1.5m€1.5m€1.5m€1.5m=
Issued capital100€1.5m€1.5m€1.5m€1.5m€1.5m=
Reserves13€108,809€120,022€150,000€150,000€150,000=
Non-distributable reserves130/1€108,809€120,022€150,000€150,000€150,000=
Legal reserve130€108,809€120,022€150,000€150,000€150,000=
Profit (loss) carried forward14-€1.5m€213,046€332,585€488,159€427,522▼ 12.4%
Provisions and deferred taxes16€31,955€21,955€0---
Provisions for liabilities and charges160/5€31,955€21,955€0---
Pensions and similar obligations160€21,955€21,955€0---
Other liabilities and charges164/5€10,000€0----
Amounts payable17/49€17.7m€13.3m€16.6m€15.9m€30.4m▲ 90.8%
Amounts payable within one year42/48€17.7m€13.3m€16.6m€15.9m€30.3m▲ 90.2%
Trade debts44€4.0m€8.0m€4.8m€11.1m€22.7m▲ 104%
Suppliers440/4€4.0m€8.0m€4.8m€11.1m€22.7m▲ 104%
Taxes, remuneration and social security45€3.5m€2.1m€2.1m€2.8m€4.6m▲ 62.8%
Taxes450/3€1.4m€948,471€861,535€1.0m€2.5m▲ 143%
Remuneration and social security454/9€2.1m€1.1m€1.2m€1.8m€2.1m▲ 16.3%
Other amounts payable47/48€10.2m€3.3m€9.8m€2.0m€2.9m▲ 50.5%
Accrued charges and deferred income492/3€0---€107,340-
Line20212022202320242025Change
Profit (loss) for the period9904€1.6m€1.7m€2.1m€2.1m€2.9m▲ 36.5%
+ Depreciation and write-downs630€351,345€421,622€343,150€269,405€220,060▼ 18.3%
Operating cash flow (approximation)€1.9m€2.2m€2.4m€2.4m€3.1m▲ 30.3%
Investment in fixed assets (approximation)--€102,970-€109,303-€152,027-€1.0m▼ 570%
Change in cash--€690,918€71€469,358-€476,994▼ 202%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
09-09
State Gazette act Miscellaneous
Power of attorney2 facts ▸
  • Board meeting, 30-08-2026
  • Power of attorney, M. A. Van den Broek
23-07
State Gazette act Resignations & appointments
Power of attorney8 facts ▸
  • Board meeting, 02-07-2026
  • Power of attorney, B. E. de Groot
  • Power of attorney, K. E. J. Laevaert
  • Power of attorney, A. Sayaghi
  • Board meeting, 02-07-2026
  • Power of attorney
  • Power of attorney
  • Board meeting, 02-07-2026
12-05
State Gazette act Reappointments: Stéphane Piret (director) and Rodrigo Da Silva Lorca Moreno (director)
Power of attorney6 facts ▸
  • General meeting, 23-04-2026
  • Power of attorney, Karen Laevaert
  • Power of attorney, Sofie de Wilder
  • Power of attorney, Laura Jacobs
  • Director reappointment, Stéphane Piret (director)
  • Director reappointment, Rodrigo Da Silva Lorca Moreno (director)
28-04
NBB filing Annual accounts filed
fiscal year 2025 · full schema
10-03
State Gazette act Resignations & appointments
Power of attorney4 facts ▸
  • Board meeting, 16-01-2026
  • Power of attorney, Head of MSL Belux (head of msl belux)
  • Board meeting, 29-01-2026
  • Power of attorney, A. Sayaghi (head of commercial excellence benelux)
2025
31-12
Financial Highest result since 2018net €2.9m ▲36.5%
Operating result €3.9m, net result €2.9m, both a record.
19-09
State Gazette act Resignations & appointments
Power of attorney12 facts ▸
  • Board meeting, 01/09/2025
  • Power of attorney, R. Da Silva Lorca Moreno
  • Power of attorney, G. Baptista Marcos Silva
  • Power of attorney, R.T.M. van der Valk
  • Power of attorney, M. Doop
  • Power of attorney, B. E. de Groot
  • Power of attorney, M. J. Reijgersberg
  • Power of attorney, E.C.J. de Rop
  • Power of attorney, R. Saidi
  • Power of attorney, M. A. van den Broek
  • Power of attorney, K. E. J. Laevaert
  • Power of attorney, K. E. J. Laevaert
02-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
13-05
State Gazette act Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
Registered-office move · Power of attorney8 facts ▸
  • Board meeting, 25-03-2025
  • Registered-office move, Luchthaven Brussel Nationaal 1K, 1930 Zaventem
  • Power of attorney, Karen Laevaert
  • Power of attorney, Laura Jacobs
  • General meeting, 24-04-2025
  • Auditor reappointment, Deloitte Bedrijfsrevisoren
  • Power of attorney, Karen Laevaert
  • Power of attorney, Laura Jacobs
2024
31-12
Financial Equity above €2mEq €2.1m ▲7.8%
4 profitable years in a row build equity to €2.1m.
14-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
02-02
State Gazette act Resignation: R. Blom (director)
Appointment: Rodrigo Lorca (director) · Mandate compensation6 facts ▸
  • General meeting, 22-12-2023
  • Director resignation, R. Blom (director)
  • Director appointment, Rodrigo Lorca (director)
  • Mandate compensation, Rodrigo Lorca
  • Board composition, Rodrigo Lorca (director)
  • Board composition, Stéphane Piret (director)
Show earlier events
2023
29-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
01-06
State Gazette act Resignation: Lucas Smink (director)
2 facts ▸
  • General meeting, 19-04-2023
  • Director resignation, Lucas Smink (director)
2022
31-12
Financial Equity above €1mEq €1.8m ▲1,929%
2 profitable years in a row build equity to €1.8m.
21-06
State Gazette act Resignations: Alberto Chiesi, Alessandro Chiesi and 3 others
Appointments: Ralph Blom (director) and Lukas (Luc) Smink (director) · Mandate compensation13 facts ▸
  • General meeting, 24-05-2022
  • Director resignation, Alberto Chiesi (director)
  • Director resignation, Alessandro Chiesi (director)
  • Director resignation, Marco Vecchia (director)
  • Director resignation, Filiz Balcay (director)
  • Director resignation, Ugo di Francesco (director)
  • Director appointment, Ralph Blom (director)
  • Director appointment, Lukas (Luc) Smink (director)
  • Mandate compensation, Ralph Blom
  • Mandate compensation, Lukas (Luc) Smink
  • Board composition, Ralph Blom (director)
  • Board composition, Lukas (Luc) Smink (director)
  • +1 further facts in this act
03-06
State Gazette act Reappointment: Deloitte Bedrijfsrevisoren (B0025) (statutory auditor)
Power of attorney3 facts ▸
  • General meeting, 28-04-2022
  • Auditor reappointment, Deloitte Bedrijfsrevisoren (B0025) (statutory auditor)
  • Power of attorney, Raoul Raaijmakers
20-05
NBB filing Annual accounts filed
fiscal year 2021 · full schema
19-05
State Gazette act Purpose · Statutes amendment
Purpose change2 facts ▸
  • General meeting, 28-04-2022
  • Purpose change, De vennootschap heeft de intentie om: (i) te opereren op een verantwoordelijke, duurzame en transparante manier ten aanzien van mensen, samenleving en het milie…
2021
31-12
Financial Back to profitnet €1.6m
Net result €1.6m after 3 loss-making years.
15-12
State Gazette act Resignation: Geert Van Hoof (director)
Power of attorney6 facts ▸
  • General meeting, 24-11-2021
  • Director resignation, Geert Van Hoof (director)
  • Board meeting, 26-11-2021
  • Power of attorney, Geert Van Hoof (general manager)
  • Power of attorney, Raoul Raaijmakers (country manager)
  • Power of attorney, Raoul Raaijmakers
26-05
NBB filing Annual accounts filed
fiscal year 2020 · full schema
09-04
State Gazette act Reappointments: Alberto Chiesi, Ugo Di Francesco and 4 others
Mandate compensation13 facts ▸
  • General meeting, 18-03-2021
  • Director reappointment, Alberto Chiesi (director)
  • Director reappointment, Ugo Di Francesco (director)
  • Director reappointment, Marco Vecchia (director)
  • Director reappointment, Alessandro Chiesi (director)
  • Director reappointment, Geert Van Hoof (director)
  • Director reappointment, Stephane Piret (director)
  • Mandate compensation, Alberto Chiesi
  • Mandate compensation, Ugo Di Francesco
  • Mandate compensation, Marco Vecchia
  • Mandate compensation, Alessandro Chiesi
  • Mandate compensation, Geert Van Hoof
  • +1 further facts in this act
18-01
State Gazette act Capital & shares · Statutes amendment · Resignations & appointments
Purpose change · Capital6 facts ▸
  • General meeting, 15/12/2020
  • Purpose change, De vennootschap heeft tot voorwerp, in België en in het buitenland, in eigen naam en voor eigen rekening, evenals in naam en voor rekening van derden: De handel…
  • Statutes amendment
  • Statutes amendment
  • Capital, €1.500.000
  • General meeting, 22/04/2021 17:00
2020
31-12
Financial Weakest financial yearnet -€1.8m
Net result drops to -€1.8m, the lowest in the series; recovery starts the following year.
13-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
04-06
State Gazette act Appointment: Filiz Balcay (director)
Power of attorney · Mandate compensation6 facts ▸
  • Board meeting, 11-03-2020
  • Power of attorney, Geert Van Hoof
  • General meeting, 07-04-2020
  • Director appointment, Filiz Balcay (director)
  • Mandate compensation, Filiz Balcay
  • Power of attorney, Geert Van Hoof
2019
29-05
State Gazette act Resignation: Danilo Piroli (director)
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)3 facts ▸
  • General meeting, 02-04-2019
  • Director resignation, Danilo Piroli (director)
  • Auditor reappointment, Deloitte Bedrijfsrevisoren
22-05
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
29-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
26-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
27-12
State Gazette act Statutes amendment
Capital · Registered-office move · Power of attorney5 facts ▸
  • General meeting, 28-11-2016
  • Statutes amendment
  • Capital, €1.500.000
  • Registered-office move, Telecomlaan 9, 1831 Diegem
  • Power of attorney
27-12
State Gazette act Appointment: Deloitte Bedrijfsrevisoren (statutory auditor)
Permanent representative: Cédric Bogaerts · Registered-office move · Statutes amendment5 facts ▸
  • General meeting, 28-11-2016
  • Registered-office move, 1831 Diegem, Telecomlaan 9
  • Statutes amendment
  • Auditor appointment, Deloitte Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Cédric Bogaerts
10-05
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 24/03/2016
  • Registered-office move, Telecomlaan 9 à 1831 Diegem
10-02
State Gazette act Permanent representative: Kristof Van Linden
Resignation: Robert Snijkers (représentant permanent du commissaire)2 facts ▸
  • Permanent representative, Kristof Van Linden (représentant permanent du commissaire)
  • Director resignation, Robert Snijkers (représentant permanent du commissaire)
2015
18-06
State Gazette act Reappointments: Albert Chiesi, Ugo Di Francesco and 4 others
Appointment: Stéphane Piret (director) · Mandate compensation9 facts ▸
  • General meeting, 22-04-2015
  • Director reappointment, Albert Chiesi (director)
  • Director reappointment, Ugo Di Francesco (director)
  • Director reappointment, Marco Vecchia (director)
  • Director reappointment, Danilo Piroli (director)
  • Director reappointment, Alessandro Chiesi (director)
  • Director reappointment, Geert Van Hoof (director)
  • Director appointment, Stéphane Piret (director)
  • Mandate compensation, Chiesi
2013
12-08
State Gazette act Resignation: Thomas Gauch (director)
Appointment: Alessandro Chiesi (director) · Director discharge · Mandate compensation5 facts ▸
  • General meeting, 01-03-2013
  • Director resignation, Thomas Gauch (director)
  • Director discharge, Thomas Gauch
  • Director appointment, Alessandro Chiesi (director)
  • Mandate compensation, Alessandro Chiesi
2012
03-08
State Gazette act Resignation: Paolo Chiesi (director)
Appointments: Ugo di Francesco (director) and Geert Van Hoof (director) · Mandate compensation6 facts ▸
  • General meeting, 01-03-2012
  • Director resignation, Paolo Chiesi (director)
  • Director appointment, Ugo di Francesco (director)
  • Director appointment, Geert Van Hoof (director)
  • Mandate compensation, Ugo di Francesco
  • Mandate compensation, Geert Van Hoof
2011
04-02
State Gazette act Resignation: Patricia Leleu (représentant permanent du commissaire)
Permanent representative: Robert Snijkers3 facts ▸
  • General meeting, 10-01-2011
  • Director resignation, Patricia Leleu (représentant permanent du commissaire)
  • Permanent representative, Robert Snijkers (représentant permanent du commissaire)
2010
01-12
State Gazette act Resignations: Thomas Ernst Gauch (managing director) and Alberto Chiesi (managing director)
Appointment: Geert Van Hoof (directeur général)4 facts ▸
  • Board meeting, 01-10-2010
  • Director resignation, Thomas Ernst Gauch (managing director)
  • Director resignation, Alberto Chiesi (managing director)
  • Director appointment, Geert Van Hoof (directeur général)
30-11
State Gazette act Appointments: Alberto Chiesi (chair of the board) and Thomas Ernst Gauch (managing director)
4 facts ▸
  • Board meeting, 23-06-2010
  • Director appointment, Alberto Chiesi (chair of the board)
  • Director appointment, Alberto Chiesi (managing director)
  • Director appointment, Thomas Ernst Gauch (managing director)
24-06
State Gazette act Incorporation
Appointments: Alberto CHIESI, Paolo CHIESI and 4 others · Permanent representative: Patricia LELEU · Founding capital12 facts ▸
  • Incorporation, 11-06-2010
  • Founding capital, €1.500.000
  • Bank account, DEUTSCHE BANK AG, 826-0006342-54
  • Director appointment, Alberto CHIESI (director)
  • Director appointment, Paolo CHIESI (director)
  • Director appointment, Thomas Ernst GAUCH (director)
  • Director appointment, Marco VECCHIA (director)
  • Director appointment, Piroli DANILO (director)
  • Mandate compensation, Alberto CHIESI
  • Auditor appointment, KPMG Reviseurs d'Entreprises (statutory auditor)
  • Permanent representative, Patricia LELEU
  • Power of attorney, Ignazio Davide MESSINA
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
27 of 27 acts read

Directors · office · real estate

Directors
5 directors, no change since 2026

Board 5

Stephane Piret
Director · since 22-04-2015
Current
Lukas (Luc) Smink
Director · since 23-05-2022
Current
Ralph Blom
Director · since 23-05-2022
Current
Rodrigo Lorca
Director · since 01-01-2024
Current
Rodrigo Da Silva Lorca Moreno
Director · since 07-04-2026
Current
1 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Albert Chiesi
Director · since 22-04-2015
Not recently confirmed

Statutory auditor 1

Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
Auditor · since 16-05-2016 · perm. rep.: Cédric Bogaerts
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 2010
seat establishment The establishment unit on the map
Ground area
76.8 ha
Building footprint
7.2 ha
Parcel 23094A0046/00E015, Flanders. Linked by address, not a title deed.
34 companies at this address See who is registered here
1 establishment unit
Chiesi
Luchthaven Brussel Nationaal 1, 1930 ZaventemWholesale of pharmaceutical and medical goods
since 20102.189.593.767
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23094A0046/00E015 Flanders 76.8 ha 1 · 7.2 ha -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

22 people since 2010, 7 in office
Show
  • Board
  • Day-to-day management
  • Permanent representative
  • Statutory auditor
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Stephane Piret
  • Director, from 22-04-2015 to date
Lukas (Luc) Smink
  • Director, from 23-05-2022 to date
Ralph Blom
  • Director, from 23-05-2022 to date
Rodrigo Lorca
  • Director, from 01-01-2024 to date
Rodrigo Da Silva Lorca Moreno
  • Director, already before 07-04-2026 to date
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
  • Auditor, from 16-05-2016 to date
Albert Chiesi
  • Director, already before 22-04-2015 not ended, last confirmed 18-06-2015
R. Blom
  • Director, until 01-01-2024
Lucas Smink
  • Director, until 19-04-2023
Alberto Chiesi
  • Director, from 11-06-2010 to 23-05-2022
  • Chair of the board, from 23-06-2010 ended, last mentioned 30-11-2010
  • Managing director, from 23-06-2010 to 01-10-2010
Alessandro Chiesi
  • Director, from 01-03-2013 to 23-05-2022
Filiz Balcay
  • Director, from 07-04-2020 to 23-05-2022
Marco Vecchia
  • Director, from 11-06-2010 to 23-05-2022
Ugo di Francesco
  • Director, from 01-03-2012 to 23-05-2022
Geert Van Hoof
  • Directeur général, from 01-10-2010 ended, last mentioned 01-12-2010
  • Director, from 01-03-2012 to 26-11-2021
Danilo Piroli
  • Director, from 11-06-2010 to 02-04-2019
KPMG Réviseurs d'Entreprises
  • Statutory auditor, from 11-06-2010 to 16-05-2016
Robert Snijkers
  • Représentant permanent du commissaire, until 01-02-2016
Thomas Gauch
  • Director, until 01-03-2013
Paolo CHIESI
  • Director, from 11-06-2010 to 01-03-2012
Patricia Leleu
  • Représentant permanent du commissaire, until 10-01-2011
Thomas Ernst GAUCH
  • Director, from 11-06-2010 ended, last mentioned 24-06-2010
  • Managing director, from 23-06-2010 to 01-10-2010
See the board, name and seat on a given date →

Articles of association

Purpose
De handel in het algemeen en, preciezer, de invoer, de uitvoer, de aankoop en de verkoop op groot- of kleinhandelsniveau, het vervoer (niet de productie) van chemische producten en…
Full purpose

De handel in het algemeen en, preciezer, de invoer, de uitvoer, de aankoop en de verkoop op groot- of kleinhandelsniveau, het vervoer (niet de productie) van chemische producten en van farmaceutische producten, evenals alle aanverwante activiteiten. Te dien einde kan de vennootschap samenwerken en deelnemen aan, of een belang nemen in andere ondernemingen, rechtstreeks of onrechtstreeks, op welke manier dan ook. De vennootschap kan zich borg stellen zowel voor haar eigen verbintenissen als voor de verbintenissen van derden, onder andere door haar goederen in hypotheek of pand te geven, met inbegrip van haar eigen handelsfonds. De vennaotschap kan in het algemeen alle commerciële, industriële, financiële, roerende en onroerende verrichtingen uitvoeren die rechtstreeks of onrechtstreeks verband houden met haar maatschappelijk doel of die van aard zijn om de verwezenlljking ervan te bevorderen.

Other statement
One provision in the deed

Structure & network

Owners and holdings

2 owners

Chain of control

  1. VALLINE S.R.L.IT ultimately, LEI
  2. CHIESI FARMACEUTICI S.P.A.IT 99.99%
  3. CHIESI

Highest known parent: VALLINE S.R.L. (Italy). The sources do not say who stands above it.

Owners 2

Holdings 0

The accounts to 31-12-2024 list no holdings, and no other source names one.

According to the 2024 annual accounts of CHIESI and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

5 current directors
Depth

The group is listed under Ownership & control below; here you explore it as a network.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Ownership & control

1 board mandate
Control over this companyparent company per the LEI register2
CHIESI FARMACEUTICI S.P.A.
Parma, Italy
VALLINE S.R.L.
Parma, Italy · indirect
controls
CHIESIBE 0826.654.883
Board mandates of this companythis company sits on their board1

Capital and shareholders

Shareholders according to the acts
At incorporation act of 24-06-2010 ↗
  • Chiesi Farmaceutici S.p.A. 149,999 shares (100%)
  • Chiesi GmbH 1 share (0%)

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 18-01-2021 Capital stated in 2 acts · 1,500,000 EUR · 150,000 shares
  2. 24-06-2010 Incorporation · 1,500,000 EUR · 150,000 shares

Public money · subsidies and aid

Flemish government

2023 · 1 entry · 1,022 EUR awarded · 1,022 EUR paid
Year Entries awardedpaid
2023 1 1,022 EUR1,022 EUR
Schemes
1 entry · 1,022 EUR · 1,022 EUR paid · Departement Werk en Sociale Economie

Recognitions · licences · registrations

Legal Entity Identifier

894500J6KE2I4SHP4I25
live in the LEI register

Similar companies · same sector, comparable size

Of 1,901 companies in sector 46460 we hold annual accounts for 1,126. 699 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded15-06-2010
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
46120Wholesale trade
46851Wholesale of industrial chemicals
49410Freight transport by road
Contact
Phone +32 2 788 42 40
Fax +32 2 788 42 11
E-invoicing
Reachable via Peppol
Peppol ID 0208:0826654883
Registered 23-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.